Peers of Integra Lifesciences Holdings Corp (IART)
Side-by-side comparison
Health Care · Health Care Equipment & Supplies
| Date | P/E Ratio |
|---|---|
| Sep 29, 2026 | -178.69x |
| Sep 28, 2026 | -174.72x |
| Sep 25, 2026 | -173.10x |
| Sep 24, 2026 | -170.53x |
| Sep 23, 2026 | -166.77x |
| Sep 22, 2026 | -172.03x |
| Sep 21, 2026 | -167.41x |
| Sep 18, 2026 | -163.44x |
Stock price divided by trailing twelve-month (TTM) GAAP earnings per share. Shows how much investors pay for each dollar of recent profit.
Latest P/E Ratio
-178.69x
Beyond P/E Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
As of Sep 29, 2026
P/E Ratio = Current Stock Price ÷ Trailing 12-Month (TTM) Diluted EPS (or Market Cap ÷ TTM Net Income). Chartloom divides stock price by trailing twelve-month EPS, calculated by dividing TTM net income by the weighted-average share count from filings. Note: Variations in share-count conventions across data providers may cause slight differences in reported P/E multiples.
Trailing P/E is based on reported GAAP results and is one of the most widely used valuation metrics.
Read the general P/E Ratio definition, formula, and analyst usage guide.
P/E Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison